Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

FDA Expands Ryzumvi Approval to Include Presbyopia

(MedPage Today) -- People with aging-associated farsightedness gained a new topical treatment option as the FDA expanded the approval of phentolamine ophthalmic solution 0.75% (Ryzumvi) to include presbyopia, according to Opus Genetics and Viatris...

FDA Expands Ryzumvi Approval to Include Presbyopia

We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.

Read the original at medpagetoday.com →

More in Health & Medicine

More from Monday 19 October →